Characteristics | Total patients | Death, N(%) | HR(95% CI)†| P |
---|---|---|---|---|
Site | Â | Â | Â | Â |
   Upper | 23 | 13(56.52) | 1 |  |
   Middle | 64 | 30(46.88) | 0.80(0.42-1.54) | 0.507 |
   Low | 33 | 15(45.45) | 0.74(0.35-1.55) | 0.424 |
TNM stage | Â | Â | ||
   T |  |  |  |  |
1 | 21 | 5(23.81) | 1 | Â |
2 | 44 | 15(34.09) | 1.52(0.55-4.20) | 0.414 |
3 | 47 | 31(65.96) | 3.80(1.47-9.79) | 0.006 |
4 | 8 | 7(87.50) | 7.65(2.40-24.32) | 0.001 |
   P for trend |  |  |  | < 0.001 |
   N |  |  |  |  |
0 | 62 | 18(29.03) | 1 | Â |
1 | 58 | 40(68.97) | 3.54(2.02-6.19) | < 0.001 |
   M |  |  |  |  |
0 | 119 | 58(48.74) | 1 | Â |
1 | 1 | 0(0) | - | - |
Clinical stage | Â | Â | Â | Â |
   1/2 | 61 | 20(32.79) | 1 |  |
   3/4 | 59 | 38(64.41) | 2.83(1.64-4.87) | < 0.001 |
Chemo-therapy | Â | Â | Â | Â |
   No | 114 | 57(50.00) | 1 |  |
   Yes | 6 | 1(16.67) | 0.25(0.03-1.79) | 0.167 |
Radio-therapy | Â | Â | Â | Â |
   No | 91 | 41(45.05) | 1 |  |
   Yes | 28 | 17(60.71) | 1.45(0.83-2.56) | 0.195 |